Diosgenin Complete Guide: Source, Process, Testing, and Selection

Herb Wiki Editorial TeamCAS 512-04-9Last updated 2026-10-29

CAS No.512-04-9
Molecular formulaC27H42O3
Relative molecular mass414.62
AppearanceWhite to off-white or pale-yellow powder / crystals
Melting point204–207 °C (literature value)
Specific rotationAbout −126° (c 1, chloroform)
AssayDiosgenin 92%–98% (HPLC, on dried basis)
Common grades92%, 95%, 98%
Test methodHPLC-UV 203 nm; acetonitrile required (methanol cut-off 205 nm)

Definition in One Sentence

Diosgenin is a spirostanol-type steroidal sapogenin, chemically (25R)-spirost-5-en-3β-ol, molecular formula C₂₇H₄₂O₃, molecular weight 414.62, CAS 512-04-9. It occurs widely in the rhizomes of Dioscorea species in the form of saponins (such as dioscin); industrially it is obtained by acid hydrolysis, solvent extraction, and crystallization. Known in the trade simply as "saponin", it is the basic raw material for synthesizing steroidal hormone drugs, with common grades of 92%–98% (HPLC).

Chemical Identity: Saponin, Two CAS Numbers, and One Epimer

Diosgenin structural formula
Fig. 1 Diosgenin structural formula: the spirostanol skeleton, (25R)-spirost-5-en-3β-ol (C27H42O3). Placeholder image, to be replaced with a real/illustrated asset.
ItemDetail
Standard Chinese nameShuyu zaosu (diosgenin); alias shuyu zaogan yuan
Industry trade nameZaosu ("saponin")
English nameDiosgenin
Chemical name(25R)-spirost-5-en-3β-ol
CAS No.512-04-9
EC No.208-134-3
Molecular formulaC₂₇H₄₂O₃
Molecular weight414.62
Compound classSteroidal sapogenin (spirostanol sapogenin)
Botanical sourceRhizomes of various Dioscorea species (Dioscorea zingiberensis, Dioscorea nipponica, etc.)
AppearanceWhite to off-white or pale-yellow powder / crystals
SolubilityFreely soluble in chloroform; soluble in ethanol (about 83 mg/mL at 25 °C) and acetic acid; practically insoluble in water
Melting point (literature)204–207 °C
Specific rotation (literature)About −126° (c 1, chloroform)
Common grades92%, 95%, 98% (HPLC)

1.1 Three Easily Confused Near Neighbours

Dioscin (C₄₅H₇₂O₁₆): the glycoside of diosgenin bearing a sugar chain — the form actually stored in the plant, and the marker compound in the Chinese Pharmacopoeia monograph for Dioscorea nipponica (HPLC-UV 203 nm). Its molecular weight is about 869, roughly twice that of diosgenin, and its water solubility is markedly better. The relationship between the two is the same "glycoside and aglycone" pairing as baicalin and baicalein: the raw material is mainly the glycoside, and commercial diosgenin is the hydrolysed aglycone.

Yamogenin (CAS 512-06-1): the 25S epimer of diosgenin (25-epi-diosgenin), with an identical molecular formula and molecular weight; it is not easy to separate at a glance on a chromatogram, and specific rotation is the practical handle for telling them apart. The two often co-exist in the raw material, so the supplier should state the basis "calculated as the 25R form" — the most easily overlooked specification variable in the diosgenin trade.

16-DPA (16-dehydropregnenolone acetate): the downstream intermediate obtained by side-chain cleavage of diosgenin, the "second step" into corticosteroid and sex-hormone synthesis. It is a different substance with a different CAS number, so "diosgenin" and "16-DPA" must not be quoted interchangeably.

Sources and Content Basis: Huangjiang, Chuanshanlong, and One Hydrolysis Line

Commercial diosgenin is almost entirely obtained by acid hydrolysis of Dioscorea rhizomes. Only a few species serve as raw material, and their positioning differs widely — huangjiang (Dioscorea zingiberensis) is the domestic workhorse, chuanshanlong (Dioscorea nipponica) is a pharmacopoeial crude drug, and Chinese yam has a low diosgenin content that must be enriched and purified.

Raw materialBotanical sourcePositioning and content basis
HuangjiangDioscorea zingiberensis C. H. WrightEndemic to China and regarded by the industry as the most important diosgenin source plant; southern Shaanxi (Ankang, Hanzhong) and northwestern Hubei are the main producing areas. The Shaanxi-registered cultivars "Xunjiang 1" and "Xunjiang 2" have rhizome diosgenin above 2.5%, and "Anjiang 2" 2.0%–3.0%; individual elite materials reported in the literature reach 16.15%, but these are exceptions — procurement should rely on batch-by-batch testing
Chuanshanlong (chuandilong)Dioscorea nipponica MakinoThe starting material for our diosgenin. A crude drug listed in the 2025 Edition, Volume I of the Chinese Pharmacopoeia; the marker compound is dioscin, not less than 1.3% calculated on the dried basis (HPLC-UV, 203 nm). Widely distributed in Northeast and North China
Chinese yamDioscorea opposita (used as both food and medicine)The pharmacopoeial yam is mainly used as a food-medicine substance; diosgenin content in the rhizome is low and must be enriched and purified. The yam extract (diosgenin 40%) is made from Chinese yam; for specification details see the Yam Extract page (coming soon)

The mass conversion of hydrolysis can be checked yourself: dioscin (C₄₅H₇₂O₁₆, about 869) loses its sugar chain on hydrolysis to give diosgenin (414.62), a theoretical mass yield of about 0.48. This gives two material-balance lines:

  • For Dioscorea nipponica at the pharmacopoeial minimum of 1.3% dioscin, one tonne of compliant herb fully hydrolysed theoretically yields about 6.2 kg of diosgenin; the actual yield must also account for extraction and purification losses;
  • For Dioscorea zingiberensis at 2.0%–3.0% in cultivated material, one tonne of dried material theoretically contains 20–30 kg — a 3–5 fold difference between two Dioscoreaceae raw materials, which is exactly why huangjiang became the mainstay of domestic diosgenin production.

Raw-material content sets the cost floor. Any quote that deviates markedly from this line is worth questioning on species, origin, and hydrolysis yield first.

Manufacturing Process: Acid Hydrolysis, Extraction, and Crystallization

Diosgenin acid hydrolysis process
Fig. 2 Diosgenin acid hydrolysis process flow: rhizome pretreatment, acid hydrolysis, solvent extraction, crystallization and purification, drying and sieving. Placeholder image, to be replaced with a real/illustrated asset.

Industrial production of diosgenin follows a three-stage route — hydrolysis, extraction, purification. The way the raw material is pretreated in the first stage changes the impurity profile in the latter two.

  1. Pretreatment: wash the rhizomes, slice or grind, and dry to increase the surface area available for hydrolysis.
  2. Acid hydrolysis: heat with dilute acid (sulfuric acid systems are common industrially) so that the sugar chains cleave and the sapogenin is released.
  3. Solvent extraction: wash the hydrolysate and extract the sapogenin with an organic solvent (solvent naphtha grades are common industrially).
  4. Crystallization and purification: recrystallize to decolorize and remove impurities, upgrading the 92% grade to 95% and 98%.
  5. Drying and sieving: dry to the moisture specification and sieve to obtain the finished powder.

What the process means for buyers: color is the most direct process signal — off-white indicates adequate purification, while greyish-yellow or brown batches usually carry higher impurities. If both melting point and specific rotation deviate from the literature ranges, suspect insufficient purity or an abnormal 25S epimer ratio. Wastewater and residue treatment in the traditional "acid hydrolysis plus gasoline extraction" process is an industry-wide environmental issue, and the sector is moving toward cleaner enzymatic and fermentation routes — for buyers, a supplier's environmental compliance directly affects its ability to keep supplying, and belongs in supplier audits.

Testing: Melting Point and Specific Rotation for Rapid Screening, HPLC for Quantification

4.1 Key Points of the Method

Diosgenin has weak UV absorption, so quantification relies mainly on HPLC-UV (about 203 nm, C18 column) — the pharmacopoeial dioscin assay for Dioscorea nipponica uses this wavelength, and the method is mature with a low equipment barrier. Rapid screening in the industry commonly uses colorimetric spectrophotometry (vanillin–sulfuric acid / perchloric acid colour development) and TLC (phosphomolybdic acid in ethanol, heated at 105 °C); both have limited specificity and suit in-plant process control, while acceptance should still be based on HPLC. Melting point and specific rotation are two low-cost, directly interpretable physical indicators — the cheapest combination for rapid identity and purity screening.

4.2 Data from a Real Batch (an example from our production)

Test itemSpecificationMeasured (batch 2026091301)
AssayDiosgenin ≥92%93.11%
AppearancePale-yellow or off-white powderOff-white powder, conforms
ClarityClear solution in 1% ethanolConforms
Melting point190 °C207 °C
Specific rotation−120° to −126°−122.5°
Moisture≤1%0.55%
Heavy metals≤10 ppmConforms
Lead (Pb)≤1.0 ppmConforms
Arsenic (As)≤1.0 ppmConforms
Total bacterial count<1000 cfu/g<100 cfu/g
E. coliNot detectedNot detected
SalmonellaNot detectedNot detected

Source: chuandilong (Dioscorea nipponica Makino); production and testing date 2026-09-13. The measured melting point of 207 °C agrees with the literature range of 204–207 °C, the specific rotation of −122.5° falls within the specification range, and microbial and heavy-metal results have ample margin — a commercial 92%+ batch of normal appearance.

4.3 Items This COA Omits That a More Complete Report Should Include

  • Related substances: the proportion of yamogenin (25S) — the most easily overlooked specification variable in the diosgenin trade;
  • Residual solvents: residues of the solvent naphtha used in hydrolysis and extraction (n-hexane and related solvents);
  • Cadmium (Cd) and mercury (Hg): testing lead and arsenic only leaves heavy-metal control incomplete;
  • Ash / residue on ignition: reflects inorganic residue;
  • Correspondence between batch assay and chromatogram: the assay figure should be traceable to a specific trace.

The full version of these methods is in Diosgenin Specifications and Test Methods: the physical cost of end absorption at 203 nm and the constraints it places on the mobile phase, the structural overestimation caused by area normalization, reading melting point and specific rotation as chemical purity and optical purity in a four-quadrant scheme, how 25R/25S isomers are controlled, and a specification-sheet field checklist you can copy directly.

Grade Selection: Above 92%, Paying for Purity Is Equally Non-Linear

Commercial diosgenin comes in three grades — 92%–93%, 95%, and 98% — determined by the downstream application and the impurity basis; higher purity is not automatically better value.

Grade (HPLC)Typical formFit-for-useKey point
92%–93%Off-white powderStarting material for steroid drug intermediates; industrial downstream processingThe commercial workhorse grade, feeding directly into the 16-DPA route
95%Off-white powderExport grades; downstream processing with colour requirementsOne additional purification round
98%White crystalline powderPharmaceutical grade, research reference standardsLarge yield loss, small batch size

Sequence for selection: define the downstream application and the impurity basis (including 25R/25S) first → then set the grade → compare prices last. For the 92% grade feeding a hormone synthesis route, what matters is batch-to-batch consistency and price; only direct trading or reference-standard use requires 98%.

Applications

Downstream uses of diosgenin are highly concentrated in steroid drug synthesis; the other uses are derived from this main line, with progressively lower purity requirements.

  • Steroid drug synthesis: the industrial starting point for corticosteroids, sex hormones, and contraceptives, entering synthetic routes through intermediates such as 16-DPA — the overwhelming mainstay of diosgenin demand.
  • Pharmaceutical intermediate trading: diosgenin itself is a global bulk intermediate commodity.
  • Health food / dietary supplement ingredient: the industry context for "wild yam" products; note the boundaries on permitted claims (see below).
  • Research reference standards: the 98% single component, supplied with batch-specific chromatograms.

Pharmacology and compliance boundaries: there is a large body of in vitro research on diosgenin (anti-inflammatory, lipid-lowering, antitumour directions), but human clinical evidence is generally limited. In particular, orally ingested diosgenin is not converted in the body to pregnenolone or progesterone, and marketing claims such as "natural progesterone" or "plant hormone replacement" have no basis and must not be used. None of the mechanistic content above may be rewritten as a disease-treatment claim.

Safety and Regulatory Status

Diosgenin has low acute toxicity, and routine toxicology data show no obvious target-organ toxicity; human data at long-term high doses are limited.

Regulatory notes (verify against the latest texts; this is not compliance advice):

  • China: diosgenin is managed mainly as a chemical/pharmaceutical intermediate, with downstream drugs subject to drug registration; it is not listed in the catalogue of substances traditionally used as both food and Chinese medicinal material, so it may not be claimed as an ordinary food ingredient. The Dioscorea nipponica crude drug and preparations containing its dioscin are governed by the pharmacopoeia and drug standards.
  • EU / US: wild yam (Dioscorea villosa and others) extracts have a history of use in dietary supplements and are managed under the relevant framework of the target market; new specifications or processes may trigger Novel Food or NDI assessment and must be confirmed case by case.

The conclusion stands: change the specification, the process, or the market, and the compliance conclusion can change with it.

Procurement and QC Checklist

Diosgenin procurement QC comes down to four things: the CAS number and the 25R basis, whether glycoside and aglycone are being conflated, whether melting point and specific rotation line up, and whether the chromatogram is traceable to the batch number.

8.1 Eight Items to Check on Every COA

  1. The assay method and detection wavelength (HPLC-UV, about 203 nm);
  2. The CAS number and the 25R/25S basis: confirm 512-04-9 and ask whether the figure is calculated as the 25R form;
  3. Melting point and specific rotation, the two rapid physical screens (against literature values of 204–207 °C and about −126°);
  4. Moisture (0.55% in this batch, indicating good drying control);
  5. Heavy metals (Pb, As; a complete report should add Cd and Hg);
  6. Residual solvents (mandatory when a solvent-naphtha extraction process is used);
  7. The three microbial items (total plate count, E. coli, Salmonella);
  8. Batch number, production/testing dates, and attached chromatograms.

8.2 Five Common Risk Points

  • Wrong CAS number: quoting 512-06-1 (yamogenin) or another incorrect number as diosgenin;
  • Glycoside/aglycone conflation: passing off a dioscin or "total saponin" figure as diosgenin content — the molecular weights differ by nearly a factor of two;
  • 25S epimer contamination: a shift in specific rotation is the first signal;
  • Off-color batches: cheap greyish-yellow or brown material carries higher impurity and residual-solvent risk;
  • Missing chromatograms: figures with no traces, or traces that do not match the batch number.

The response is to demand the chromatograms, a statement of the 25R basis, and batch-by-batch correspondence, and to have key items retested by a third party.

Frequently Asked Questions

Q1: What is the relationship between diosgenin and dioscin?

Aglycone and glycoside. The raw material is mainly dioscin (C₄₅H₇₂O₁₆), while commercial diosgenin is the aglycone (C₂₇H₄₂O₃) after hydrolysis removes the sugar chain, with the molecular weight dropping from about 869 to 414.62. The pharmacopoeial marker for Dioscorea nipponica is dioscin, whereas the trade basis is diosgenin; the two assays cannot be compared directly.

Q2: Is diosgenin's CAS number 512-04-9 or 512-06-1?

Diosgenin ((25R)-spirost-5-en-3β-ol) is 512-04-9 (NIST, Sigma-Aldrich, and PubChem agree); 512-06-1 is its 25S epimer, yamogenin. Some sources use the two interchangeably; when purchasing, the safest check is the structural formula plus EC number 208-134-3.

Q3: What does a deviation in melting point or specific rotation indicate?

They are the cheapest purity and isomer screens: a melting point below the literature range usually indicates higher impurities; a specific rotation shifted positive (a smaller absolute value) indicates a rising 25S epimer fraction. If either deviates markedly, it is worth adding HPLC and related-substance testing.

Q4: Is diosgenin water-soluble?

Practically insoluble in water (<1 mg/mL); freely soluble in chloroform, soluble in ethanol and acetic acid. The single-component sapogenin is of little use in aqueous systems; formulations generally use the saponin or extract form.

Q5: Why is the price gap between 92% and 98% so large?

Going from 92% to 98% requires additional recrystallization, with large yield losses and small batch sizes, so cost rises non-linearly. For downstream customers feeding a hormone synthesis route, the 92% grade is the most economical.

Q6: Is there a difference between diosgenin made from huangjiang and from chuanshanlong?

Same molecule; once the specification is met, they are equivalent. The difference lies in raw-material content and cost structure: cultivated huangjiang contains 2.0%–3.0% diosgenin, while the pharmacopoeial minimum for dioscin in chuanshanlong is 1.3%. Asking the supplier to state the botanical source predicts batch-to-batch consistency better than comparing prices alone.

Q7: Can oral diosgenin "supplement hormones"?

No. There is no evidence that orally ingested diosgenin is converted to pregnenolone or progesterone in the body; "natural progesterone" is marketing language. The industrial value of diosgenin lies in being a feedstock for chemical synthesis, not in replacing hormones orally.

Q8: What is the relationship between yam extract (diosgenin 40%) and diosgenin?

The former is a standardized extract with diosgenin content as its marker (≥40%); the latter is a high-purity single component. They share the same testing logic (HPLC 203 nm, melting point, specific rotation) but differ in specification and use; see the Yam Extract page for details.

Q9: Can diosgenin be used in ordinary foods?

Diosgenin is not listed in China's food-medicine substances catalogue and may not be claimed as an ordinary food ingredient; dietary-supplement use must be confirmed case by case under target-market regulations.

Q10: Is slight color variation between batches of the same grade normal?

Yes. Plant-derived material varies with species, origin, and the age of the rhizomes; off-white to pale yellow are all common forms. Marked greying or browning is the real process or storage signal, and should be read together with melting point and specific rotation.

References and Search Suggestions

  1. NIST Chemistry WebBook, CAS Registry Number 512-04-9 (physicochemical and spectral data for diosgenin).
  2. PubChem CID 99474 (standardized structure and identifiers for diosgenin; CAS Common Chemistry also lists 512-04-9).
  3. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2025 Edition, Volume I), monograph "Dioscorea nipponica" (dioscin limit and HPLC-UV 203 nm method).
  4. Reviews of diosgenin pharmacology and clinical research: PubMed search query "diosgenin"[Title/Abstract] AND review[pt], limited to the past five years.
  5. Shaanxi Provincial People's Government Gazette (1998) and the Shaanxi Provincial Forestry Department cultivar registration announcement (2009): the official sources for the suitable growing areas of huangjiang and the 2.0%–3.0% diosgenin content of registered cultivars.

Items 1, 2, and 4 give search paths rather than specific citations; follow them to retrieve and verify the original sources when needed.

Disclaimer

This article is technical reference material on raw materials, intended for R&D, procurement, and quality personnel; it does not constitute medical advice, dosing guidance, or compliance advice. Assay, process, and regulatory information change as standards are revised; for actual transactions and filings, rely on the latest official standards, the terms agreed in the contract, and third-party test reports.